{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:40:08Z","timestamp":1759333208253},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1006\/bcmd.2002.0530","type":"journal-article","created":{"date-parts":[[2002,12,27]],"date-time":"2002-12-27T15:40:24Z","timestamp":1041003624000},"page":"1-13","source":"Crossref","is-referenced-by-count":25,"title":["Genomic Imbalances in Drug-Resistant T-Cell Acute Lymphoblastic CEM Leukemia Cell Lines"],"prefix":"10.1006","volume":"29","author":[{"given":"Thomas","family":"Efferth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irmgard","family":"Verdorfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Sauerbrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans G.","family":"Drexler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"Chitambar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Haber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich","family":"Gebhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/bcmd.2002.0530_RF1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1566524013364194","article-title":"The human ATP-binding cassette transporter genes: from the bench to the bedside","volume":"1","author":"Efferth","year":"2001","journal-title":"Curr. Mol. Med"},{"key":"10.1006\/bcmd.2002.0530_RF2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0306-3623(97)00383-2","article-title":"Tumor resistance to antimetabolites","volume":"30","author":"Kinsella","year":"1998","journal-title":"Gen. Pharmacol"},{"key":"10.1006\/bcmd.2002.0530_RF3","first-page":"2905","article-title":"Multidrug resistance and its reversal","volume":"18","author":"Volm","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1006\/bcmd.2002.0530_RF4","first-page":"143","article-title":"Resistance to cisplatin","volume":"14","author":"Akiyama","year":"1999","journal-title":"Anticancer Drug Des"},{"key":"10.1006\/bcmd.2002.0530_RF5","first-page":"5927","article-title":"Genes amplified and overexpressed in human multidrug-resistant cell lines","volume":"48","author":"van der Bliek","year":"1988","journal-title":"Cancer Res"},{"key":"10.1006\/bcmd.2002.0530_RF6","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1128\/MCB.18.5.3089","article-title":"Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage","volume":"18","author":"Paulson","year":"1998","journal-title":"Mol. Cell. Biol"},{"key":"10.1006\/bcmd.2002.0530_RF7","first-page":"4237","article-title":"The mouse Bcrp1\/Mxr\/Abcp gene: Amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin","volume":"59","author":"Allen","year":"1999","journal-title":"Cancer Res"},{"key":"10.1006\/bcmd.2002.0530_RF8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0002-9440(10)64952-8","article-title":"Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer","volume":"156","author":"Jarvinen","year":"2000","journal-title":"Am. J. Pathol"},{"key":"10.1006\/bcmd.2002.0530_RF9","first-page":"383","article-title":"Patterns of genomic imbalances in human solid tumors (review)","volume":"16","author":"Gebhart","year":"2000","journal-title":"Int. J. Oncol"},{"key":"10.1006\/bcmd.2002.0530_RF10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/(SICI)1098-2264(199704)18:4<286::AID-GCC6>3.0.CO;2-X","article-title":"Comparative genomic hybridization analysis of chromosomal hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells","volume":"18","author":"Wasenius","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1006\/bcmd.2002.0530_RF11","first-page":"5042","article-title":"Comparative genomic hybridization analysis of chromosomal alterations induced by the development of resistance to thymidylate synthase inhibitors","volume":"58","author":"Rooney","year":"1998","journal-title":"Cancer Res"},{"key":"10.1006\/bcmd.2002.0530_RF12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-4608(98)00222-2","article-title":"Characterization of drug-resistant cell lines by comparative genomic hybridization","volume":"111","author":"Carlson","year":"1999","journal-title":"Cancer Genet. Cytogenet"},{"key":"10.1006\/bcmd.2002.0530_RF13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0162-0134(99)00140-3","article-title":"A molecular cytogenetic approach to studying platinum resistance","volume":"77","author":"Hiorns","year":"1999","journal-title":"J. Inorg. Biochem"},{"key":"10.1006\/bcmd.2002.0530_RF14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0002-9440(10)65102-4","article-title":"Genomic imbalances associated with acquired resistance to platinum analogues","volume":"155","author":"Leyland-Jones","year":"1999","journal-title":"Am. J. Pathol"},{"key":"10.1006\/bcmd.2002.0530_RF15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000015451","article-title":"Association of genomic imbalances with resistance to therapeutic drugs in human melanoma cell lines","volume":"87","author":"Nessling","year":"1999","journal-title":"Cytogenet. Cell. Genet"},{"key":"10.1006\/bcmd.2002.0530_RF16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/(SICI)1098-2264(200001)27:1<110::AID-GCC14>3.0.CO;2-4","article-title":"Amplification of 4q21-q22 and the MXR gene in independently derived mitoxanthrone-resistant cell lines","volume":"27","author":"Knutsen","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1006\/bcmd.2002.0530_RF17","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/jnci\/81.16.1250","article-title":"Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate","volume":"81","author":"Haber","year":"1989","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1006\/bcmd.2002.0530_RF18","first-page":"6793","article-title":"Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells","volume":"50","author":"Kimmig","year":"1990","journal-title":"Cancer Res"},{"key":"10.1006\/bcmd.2002.0530_RF19","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1349-7006.1997.tb00467.x","article-title":"Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate","volume":"88","author":"Miyachi","year":"1997","journal-title":"Jpn. J. Cancer Res"},{"key":"10.1006\/bcmd.2002.0530_RF20","first-page":"439","article-title":"Increased sensitivity of hydroxyurea-resistant leukemic cells to gemcitabine","volume":"5","author":"Wong","year":"1999","journal-title":"Clin. Cancer Res"},{"key":"10.1006\/bcmd.2002.0530_RF21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/(SICI)1097-0215(19960301)65:5<613::AID-IJC10>3.0.CO;2-8","article-title":"Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate","volume":"65","author":"Norris","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1006\/bcmd.2002.0530_RF22","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.leu.2402128","article-title":"High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance","volume":"15","author":"Catts","year":"2001","journal-title":"Leukemia"},{"key":"10.1006\/bcmd.2002.0530_RF23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0304-3835(90)90102-4","article-title":"Phenotypic and cytogenetic analysis of atypical multidrug resistance in human leukaemic cells selected with methotrexate at high concentration","volume":"51","author":"Kavallaris","year":"1990","journal-title":"Cancer Lett"},{"key":"10.1006\/bcmd.2002.0530_RF24","first-page":"4361","article-title":"Effect of hydroxyurea on cellular iron metabolism in human leukemic CCRF-CEM cells: Changes in iron uptake and the regulation of transferrin receptor and ferritin gene expression following inhibition of DNA synthesis","volume":"55","author":"Chitambar","year":"1995","journal-title":"Cancer Res"},{"key":"10.1006\/bcmd.2002.0530_RF25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0304-3835(95)03950-2","article-title":"An assay for the determination of reduced methotrexate accumulation in cells displaying limited viability in vitro","volume":"97","author":"Haber","year":"1995","journal-title":"Cancer Lett"},{"key":"10.1006\/bcmd.2002.0530_RF26","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0145-2126(97)00052-0","article-title":"A novel method for direct and fluorescence independent determination of drug efflux out of leukemic blast cells","volume":"21","author":"Schaich","year":"1997","journal-title":"Leuk. Res"},{"key":"10.1006\/bcmd.2002.0530_RF27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF01208836","article-title":"Methotrexate cytotoxicity determination using the MTT assay following enzymatic depletion of thymidine and hypoxanthine","volume":"119","author":"Haber","year":"1993","journal-title":"J. Cancer Res. Clin. Oncol"},{"key":"10.1006\/bcmd.2002.0530_RF28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0922-4106(94)90015-9","article-title":"Dexniguldipine\u2013HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells","volume":"288","author":"Malkhandi","year":"1994","journal-title":"Eur. J. Pharmacol"},{"key":"10.1006\/bcmd.2002.0530_RF29","first-page":"21","article-title":"B9209-005, an azido derivative of the chemosensitizer dexniguldipine\u2013HCl, photolabels P-glycoprotein","volume":"48","author":"Borchers","year":"1995","journal-title":"Mol. Pharmacol"},{"key":"10.1006\/bcmd.2002.0530_RF30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1365-2141.1996.d01-1938.x","article-title":"Superantigen-mediated cellular cytotoxicity is dependent on antigen expression, but independent of the P-glycoprotein multidrug resistance phenotype","volume":"95","author":"Zehrer","year":"1996","journal-title":"Br. J. Haematol"},{"key":"10.1006\/bcmd.2002.0530_RF31","first-page":"19","article-title":"Frequent gains and losses of specific chromosome segments in human ovarian carcinomas shown by comparative genomic hybridization","volume":"11","author":"Wolff","year":"1997","journal-title":"Int. J. Oncol"},{"key":"10.1006\/bcmd.2002.0530_RF32","first-page":"1099","article-title":"Delimiting the use of comparative genomic hybridization in human myeloid neoplastic disorders","volume":"16","author":"Gebhart","year":"2000","journal-title":"Int. J. Oncol"},{"key":"10.1006\/bcmd.2002.0530_RF33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(00)00287-9","article-title":"Comparative genomic hybridization-aided unraveling of complex karyotypes in human hematopoietic neoplasias","volume":"124","author":"Verdorfer","year":"2001","journal-title":"Cancer Genet. Cytogenet"},{"key":"10.1006\/bcmd.2002.0530_RF34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ijc.2910540213","article-title":"Appearance of amplified thymidylate synthase or dihydrofolate reductase genes in stage-IV breast-cancer patients receiving endocrine treatment","volume":"54","author":"L\u00f6nn","year":"1993","journal-title":"Int. J. Cancer"},{"key":"10.1006\/bcmd.2002.0530_RF35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/cmb.1999.6.37","article-title":"Inferring tree models for oncogenesis from comparative genome hybridization data","volume":"6","author":"Desper","year":"1999","journal-title":"J. Comput. Biol"},{"key":"10.1006\/bcmd.2002.0530_RF36","first-page":"4260","article-title":"Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors","volume":"58","author":"Rao","year":"1998","journal-title":"Cancer Res"},{"key":"10.1006\/bcmd.2002.0530_RF37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1098-2264(199907)25:3<261::AID-GCC8>3.0.CO;2-#","article-title":"1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment","volume":"25","author":"Hirai","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1006\/bcmd.2002.0530_RF38","first-page":"2526","article-title":"Gains of 1q21-q22 and 13q12-q14 are potential indicators for resistance to cisplatin-based chemotherapy in ovarian cancer patients","volume":"5","author":"Kudoh","year":"1999","journal-title":"Clin. Cancer Res"},{"key":"10.1006\/bcmd.2002.0530_RF39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0165-4608(98)00195-2","article-title":"Physical mapping of a tandem duplication on the long arm of chromosome 7 associated with a multidrug-resistant phenotype","volume":"110","author":"de Silva","year":"1999","journal-title":"Cancer Genet. Cytogenet"},{"key":"10.1006\/bcmd.2002.0530_RF40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1034\/j.1600-0609.2000.9c153.x","article-title":"Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance","volume":"65","author":"Koski","year":"2000","journal-title":"Eur. J. Haematol"},{"key":"10.1006\/bcmd.2002.0530_RF41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s100380050178","article-title":"Chromosomal imbalances in adult T-cell leukemia revealed by comparative genomic hybridization: gains at 14q32 and 2p16-22 in cell lines","volume":"44","author":"Ariyama","year":"1999","journal-title":"J. Hum. Genet"},{"key":"10.1006\/bcmd.2002.0530_RF42","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood.V97.12.3875","article-title":"Comparative genomic hybridization analysis in adult T-cell leukemia\/lymphoma: Correlation with clinical course","volume":"97","author":"Tsukasaki","year":"2001","journal-title":"Blood"},{"key":"10.1006\/bcmd.2002.0530_RF43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0304-3835(90)90102-4","article-title":"Phenotypic and cytogenetic analysis of atypical multidrug resistance in human leukaemic cells selected with methotrexate at high concentration","volume":"51","author":"Kavallaris","year":"1990","journal-title":"Cancer Lett"},{"key":"10.1006\/bcmd.2002.0530_RF44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ng1095-210","article-title":"Frequency of homozygous deletion at p16\/CDKN2 in primary human tumours","volume":"11","author":"Cairns","year":"1995","journal-title":"Nat. Genet"},{"key":"10.1006\/bcmd.2002.0530_RF45","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0092-8674(00)81400-2","article-title":"The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2\u2032s inhibition of p53","volume":"92","author":"Pomerantz","year":"1998","journal-title":"Cell"},{"key":"10.1006\/bcmd.2002.0530_RF46","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/35096061","article-title":"The ink4a\/arf network in tumour suppression","volume":"2","author":"Sherr","year":"2001","journal-title":"Nat. Rev. Mol. Cell. Biol"},{"key":"10.1006\/bcmd.2002.0530_RF47","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood.V85.10.2685.bloodjournal85102685","article-title":"Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features","volume":"85","author":"Fizzotti","year":"1995","journal-title":"Blood"},{"key":"10.1006\/bcmd.2002.0530_RF48","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1182\/blood.V89.11.4161","article-title":"Homozygous deletion of the p16\/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome","volume":"11","author":"Kees","year":"1997","journal-title":"Blood"},{"key":"10.1006\/bcmd.2002.0530_RF49","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1101\/SQB.1978.042.01.067","article-title":"Amplification of dihydrofolate reductase genes in methotrexate-resistant cultured mouse cells","volume":"42","author":"Schimke","year":"1978","journal-title":"Cold Spring Harb. Symp. Quant. Biol"},{"key":"10.1006\/bcmd.2002.0530_RF50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ijc.2910480117","article-title":"Increased methotrexate-induced DNA strand breaks and cytotoxicity following mutational loss of thymidine kinase","volume":"48","author":"Sano","year":"1991","journal-title":"Int. J. Cancer"},{"key":"10.1006\/bcmd.2002.0530_RF51","first-page":"1328","article-title":"Overexpression of ribonucleotide reductase in transfected human KB cells increases their resistance to hydroxyurea: M2 but not M1 is sufficient to increase resistance to hydroxyurea in transfected cells","volume":"55","author":"Zhou","year":"1995","journal-title":"Cancer Res"},{"key":"10.1006\/bcmd.2002.0530_RF52","first-page":"4876","article-title":"Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability","volume":"57","author":"Huang","year":"1997","journal-title":"Cancer Res"},{"key":"10.1006\/bcmd.2002.0530_RF53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s004419900160","article-title":"Apoptosis and cancer chemotherapy","volume":"301","author":"Makin","year":"2000","journal-title":"Cell Tissue Res"},{"key":"10.1006\/bcmd.2002.0530_RF54","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1038\/sj.onc.1204342","article-title":"Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance","volume":"20","author":"Friedrich","year":"2001","journal-title":"Oncogene"},{"key":"10.1006\/bcmd.2002.0530_RF55","first-page":"2325","article-title":"Role of the cellular oxidation\u2013reduction state in methotrexate-binding to dihydrofolate reductase and dissociation induced by reduced folates","volume":"44","author":"Matherly","year":"1984","journal-title":"Cancer Res"},{"key":"10.1006\/bcmd.2002.0530_RF56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0145-2126(91)90098-E","article-title":"Effect of nitrous oxide and methotrexate on folate coenzyme pools of blast cells from leukemia patients","volume":"15","author":"Ermens","year":"1991","journal-title":"Leuk. Res"},{"key":"10.1006\/bcmd.2002.0530_RF57","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/(SICI)1097-0215(19981023)79:5<468::AID-IJC4>3.0.CO;2-Z","article-title":"Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy","volume":"79","author":"Vargas-Roig","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1006\/bcmd.2002.0530_RF58","doi-asserted-by":"crossref","first-page":"14418","DOI":"10.1073\/pnas.96.25.14418","article-title":"Genomic analysis of human and mouse TCL1 loci reveals a complex of tightly clustered genes","volume":"96","author":"Hallas","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/bcmd.2002.0530_RF59","first-page":"4293","article-title":"Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide","volume":"55","author":"Yokomito","year":"1995","journal-title":"Cancer Res"},{"key":"10.1006\/bcmd.2002.0530_RF60","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1182\/blood.V89.7.2480","article-title":"Possible role of an adult T-cell leukemia (ATL)-derived factor\/thioredoxin in the drug resistance of ATL to adriamycin","volume":"89","author":"Wang","year":"1997","journal-title":"Blood"},{"key":"10.1006\/bcmd.2002.0530_RF61","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/MCB.8.2.884","article-title":"Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation","volume":"8","author":"Clarke","year":"1988","journal-title":"Mol. Cell. Biol"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979602905309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979602905309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T13:26:02Z","timestamp":1583414762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979602905309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S1079979602905309"],"URL":"https:\/\/doi.org\/10.1006\/bcmd.2002.0530","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}